Rubitecan
- Level
- Commodity
- Parent
- 51111600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51111655This classification denotes a camptothecin analogue with the molecular formula C20H15N3O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H19C446XXB, chemically known as 4-ethyl-4-hydroxy-9-nitro-1h-pyrano(3,4:6,7)indolizino(1,2-b)quinoline-3,14(4h,12h)-dione but generally known as rubitecan, which bears US NIH Compound Identifier 123613. European Medicines Agency schedules Rubitecan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB33089. The term RUBITECAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 3, 2000, List 44). Most nations schedule rubitecan under HS 29399900 and SITC 54149. As of Q4 2014, RUBITECAN remains the US FDA Preferred Term for this commodity. Rubitecan bears US NLM identifiers UMLS ID C0213800 and NCI Concept Code C1485. SMILES: O1CC2C(C(O)(CC)C1=O)CC1N(CC3C1NC1C(C3)C([N](=O)O)CCC1)C2=O.
Same parent
Under 51111600 · 55Activities that produce or sell this
KBLI · 8Inherited from family 51110000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.